Skip to main content

Crimean-Congo hemorrhagic fever: An overview

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic viral infection that is a serious threat to humans. The disease is widely distributed in Africa, Asia, and Europe and has developed into a serious public health concern. Humans become infected through the bites of ticks, by contact with a patient with CCHF, or by contact with blood or tissues from viremic livestock. Microvascular instability and impaired hemostasis are the hallmarks of the infection. Infection in human begins with nonspecific febrile symptoms, but may progress to a serious hemorrhagic syndrome with high mortality rates. Enzyme-linked immunoassay (ELISA) and polymerase chain reaction (PCR) are the most used and specific tests for the diagnosis. The mainstay of treatment is supportive. Although definitive studies are not available, ribavirin is suggested to be effective especially at the earlier phase of the infection. Uses of universal protective measures are the best way to avoid the infection. In this review, all aspects of CCHF are overviewed in light of the current literature.

References

  • Anagnostou V, and Papa A. 2009. Evolution of Crimean-Congo Hemorrhagic Fever virus. Infect Genet Evol, 9: 948–954.

    PubMed  Article  CAS  Google Scholar 

  • Appannanavar S B, and Mishra B. 2011. An update on crimean congo hemorrhagic Fever. J Glob Infect Dis, 3: 285–292.

    PubMed  Article  Google Scholar 

  • Ascioglu S, Leblebicioglu H, Vahaboglu H, and Chan K A. 2011. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother, 66: 1215–1222.

    PubMed  Article  CAS  Google Scholar 

  • Atkinson B, Chamberlain J, Logue C H, Cook N, Bruce C, Dowall S D, and Hewson R. 2012. Development of a real-time rt-PCR assay for the detection of crimean-congo hemorrhagic Fever virus. Vector Borne Zoonotic Dis, 12: 786–793.

    PubMed  Article  Google Scholar 

  • Bajpai S, and Nadkar M Y. 2011. Crimean Congo hemorrhagic fever: requires vigilance and not panic. J Assoc Physicians India, 59: 164–167.

    PubMed  Google Scholar 

  • Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran M A, and Vahaboglu H. 2005. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol, 54: 385–389.

    PubMed  Article  Google Scholar 

  • Bakir M, Engin A, Gozel M G, Elaldi N, Kilickap S, and Cinar Z. 2012. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis, 49: 105–110.

    PubMed  Google Scholar 

  • Bangash S A, and Khan E A. 2003. Treatment and prophylaxis with ribavirin for Crimean-Congo Hemorrhagic Fever—is it effective? J Pak Med Assoc, 53: 39–41.

    PubMed  CAS  Google Scholar 

  • Bente D A, Alimonti J B, Shieh W J, Camus G, Stroher U, Zaki S, and Jones S M. 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol, 84: 11089–11100.

    PubMed  Article  CAS  Google Scholar 

  • Bodur H, Akinci E, Ascioglu S, Onguru P, and Uyar Y. 2012. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis, 18: 640–642.

    PubMed  Article  Google Scholar 

  • Bodur H, Akinci E, Onguru P, Uyar Y, Basturk B, Gozel M G, and Kayaaslan B U. 2010. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis, 14: e704–707.

    PubMed  Article  CAS  Google Scholar 

  • Bodur H, Erbay A, Akinci E, Onguru P, Bayazit N, Eren S S, and Kubar A. 2011. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. Int J Infect Dis, 15: e44–47.

    PubMed  Article  CAS  Google Scholar 

  • Burt F J, Leman P A, Abbott J C, and Swanepoel R. 1994. Serodiagnosis of Crimean-Congo haemorrhagic fever. Epidemiol Infect, 113: 551–562.

    PubMed  Article  CAS  Google Scholar 

  • Cevik M A, Erbay A, Bodur H, Eren S S, Akinci E, Sener K, Onguru P, and Kubar A. 2007. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis, 45: e96–100.

    PubMed  Article  Google Scholar 

  • Cherenov I V, Galimzianov K M, Sologub T V, Romantsov M G, Lokteva O M, and Kovalenko A L. 2012. Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever. Klin Med (Mosk), 90: 59–62.

    CAS  Google Scholar 

  • Chinikar S, Ghiasi S M, Hewson R, Moradi M, and Haeri A. 2010. Crimean-Congo hemorrhagic fever in Iran and neighboring countries. J Clin Virol, 47: 110–114.

    PubMed  Article  CAS  Google Scholar 

  • Deyde V M, Khristova M L, Rollin P E, Ksiazek T G, and Nichol S T. 2006. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol, 80: 8834–8842.

    PubMed  Article  CAS  Google Scholar 

  • Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, and Gunther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol, 40: 2323–2330.

    PubMed  Article  CAS  Google Scholar 

  • Duh D, Nichol S T, Khristova M L, Saksida A, Hafner-Bratkovic I, Petrovec M, Dedushaj I, Ahmeti S, and Avsic-Zupanc T. 2008. The complete genome sequence of a Crimean-Congo hemorrhagic fever virus isolated from an endemic region in Kosovo. Virol J, 5: 7.

    PubMed  Article  Google Scholar 

  • Duygu F, Kaya T, and Baysan P. 2012. Re-evaluation of 400 crimean-congo hemorrhagic Fever cases in an endemic area: is ribavirin treatment suitable? Vector Borne Zoonotic Dis, 12: 812–816.

    PubMed  Article  Google Scholar 

  • Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, Leblebicioglu H, Yilmaz N, Engin A, Sencan M, Aydin K, Dokmetas I, Cevik M A, Dokuzoguz B, Tasyaran M A, Ozturk R, Bakir M, and Uzun R. 2009. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect, 58: 238–244.

    PubMed  Article  Google Scholar 

  • Erduran E, and Cakir M. 2010. Reactive hemophagocytic lymphohistiocytosis and Crimean-Congo hemorrhagic fever. Int J Infect Dis, 14Suppl 3: e349; author reply e350.

    PubMed  Article  Google Scholar 

  • Ergonul O. 2006. Crimean-Congo haemorrhagic fever. Lancet Infect Dis, 6: 203–214.

    PubMed  Article  Google Scholar 

  • Ergonul O. 2008. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res, 78: 125–131.

    PubMed  Article  CAS  Google Scholar 

  • Ergonul O. 2012. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol, 2: 215–220.

    PubMed  Article  Google Scholar 

  • Ergonul O, Tuncbilek S, Baykam N, Celikbas A, and Dokuzoguz B. 2006. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis, 193: 941–944.

    PubMed  Article  CAS  Google Scholar 

  • Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, and Esener H. 2004. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis, 39: 284–287.

    PubMed  Article  Google Scholar 

  • Ertugrul B, Kirdar S, Ersoy O S, Ture M, Erol N, Ozturk B, and Sakarya S. 2012. The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia. Scand J Infect Dis, 44: 276–281.

    PubMed  Article  Google Scholar 

  • Ertugrul B, Uyar Y, Yavas K, Turan C, Oncu S, Saylak O, Carhan A, Ozturk B, Erol N, and Sakarya S. 2009. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Int J Infect Dis, 13: e431–436.

    PubMed  Article  Google Scholar 

  • Fisher-Hoch S P, Khan J A, Rehman S, Mirza S, Khurshid M, and McCormick J B. 1995. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet, 346: 472–475.

    PubMed  Article  CAS  Google Scholar 

  • Geisbert T W, and Jahrling P B. 2004. Exotic emerging viral diseases: progress and challenges. Nat Med, 10: S110–121.

    PubMed  Article  CAS  Google Scholar 

  • Hewson R, Chamberlain J, Mioulet V, Lloyd G, Jamil B, Hasan R, Gmyl A, Gmyl L, Smirnova S E, Lukashev A, Karganova G, and Clegg C. 2004. Crimean-Congo haemorrhagic fever virus: sequence analysis of the small RNA segments from a collection of viruses world wide. Virus Res, 102: 185–189.

    PubMed  Article  CAS  Google Scholar 

  • Heyman P, Cochez C, Hofhuis A, van der Giessen J, Sprong H, Porter S R, Losson B, Saegerman C, Donoso-Mantke O, Niedrig M, and Papa A. 2010. A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect Ther, 8: 33–50.

    PubMed  Article  Google Scholar 

  • Humolli I, Dedushaj I, Zupanac T A, and Mucaj S. 2010. Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo. Med Arh, 64: 91–93.

    PubMed  Google Scholar 

  • Ibrahim S M, Aitichou M, Hardick J, Blow J, O’Guinn M L, and Schmaljohn C. 2011. Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR. Methods Mol Biol, 665: 357–368.

    PubMed  Article  CAS  Google Scholar 

  • Izadi S, and Salehi M. 2009. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis, 62: 11–15.

    PubMed  CAS  Google Scholar 

  • Jameson L J, Morgan P J, Medlock J M, Watola G, and Vaux A G. 2012. Importation of Hyalomma marginatum, vector of Crimean-Congo haemorrhagic fever virus, into the United Kingdom by migratory birds. Ticks Tick Borne Dis, 3: 95–99.

    PubMed  Article  Google Scholar 

  • Kebede S, Duales S, Yokouide A, and Alemu W. 2010. Trends of major disease outbreaks in the African region, 2003–2007. East Afr J Public Health, 7: 20–29.

    PubMed  Google Scholar 

  • Keshtkar-Jahromi M, Kuhn J H, Christova I, Bradfute S B, Jahrling P B, and Bavari S. 2011. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res, 90: 85–92.

    PubMed  Article  CAS  Google Scholar 

  • Koksal I, Yilmaz G, Aksoy F, Aydin H, Yavuz I, Iskender S, Akcay K, Erensoy S, Caylan R, and Aydin K. 2010. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol, 47: 65–68.

    PubMed  Article  CAS  Google Scholar 

  • Kubar A, Haciomeroglu M, Ozkul A, Bagriacik U, Akinci E, Sener K, and Bodur H. 2011. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis, 64: 439–443.

    PubMed  CAS  Google Scholar 

  • Leblebicioglu H. 2010. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents, 36Suppl 1: S43–46.

    PubMed  Article  CAS  Google Scholar 

  • Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I, Kurt H, and Senturk G C. 2012. Case management and supportive treatment for patients with crimean-congo hemorrhagic Fever. Vector Borne Zoonotic Dis, 12: 805–811.

    PubMed  Article  Google Scholar 

  • Mardani M, and Keshtkar-Jahromi M. 2007. Crimean-Congo hemorrhagic fever. Arch Iran Med, 10: 204–214.

    PubMed  Google Scholar 

  • Mardani M, Rahnavardi M, Rajaeinejad M, Naini K H, Chinikar S, Pourmalek F, Rostami M, and Shahri M H. 2007. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg, 76: 443–445.

    PubMed  Google Scholar 

  • Marty A M, Jahrling P B, and Geisbert T W. 2006. Viral hemorrhagic fevers. Clin Lab Med, 26: 345–386, viii.

    PubMed  Article  Google Scholar 

  • Mofleh J, and Ahmad Z. 2012. Crimean-Congo haemorrhagic fever outbreak investigation in the Western Region of Afghanistan in 2008. East Mediterr Health J, 18: 522–526.

    PubMed  CAS  Google Scholar 

  • Mourya D T, Yadav P D, Shete A M, Gurav Y K, Raut C G, Jadi R S, Pawar S D, Nichol S T, and Mishra A C. 2012. Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010–2011. PLoS Negl Trop Dis, 6: e1653.

    PubMed  Article  CAS  Google Scholar 

  • Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, and Tasyaran M A. 2006. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect, 52: 207–215.

    PubMed  Article  Google Scholar 

  • Ozturk B, Tutuncu E, Kuscu F, Gurbuz Y, Sencan I, and Tuzun H. 2012. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int J Infect Dis, 16: e89–93.

    PubMed  Article  Google Scholar 

  • Papa A, Papadimitriou E, and Christova I. 2011. The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain. Scand J Infect Dis, 43: 225–229.

    PubMed  Article  Google Scholar 

  • Papa A, Bino S, Velo E, Harxhi A, Kota M, and Antoniadis A. 2006. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol, 36: 272–276.

    PubMed  Article  CAS  Google Scholar 

  • Purnak T, Selvi N A, and Altundag K. 2007. Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever. Med Hypotheses, 68: 924–925.

    PubMed  Article  Google Scholar 

  • Putilina N G, Azarian A R, Trusova I N, Mal’kov P M, Grishanova A P, Kovtunov A I, Shendo G L, Dzharkenov A F, Arshba T E, Larichev V F, and Butenko A M. 2011. Use of RT-PCR and enzyme immunoassays for the specific diagnosis of Crimean hemorrhagic fever. Vopr Virusol, 56: 34–38.

    PubMed  CAS  Google Scholar 

  • Saijo M, Tang Q, Shimayi B, Han L, Zhang Y, Asiguma M, Tianshu D, Maeda A, Kurane I, and Morikawa S. 2004. Possible horizontal transmission of crimean-congo hemorrhagic Fever virus from a mother to her child. Jpn J Infect Dis, 57: 55–57.

    PubMed  Google Scholar 

  • Saijo M, Tang Q, Shimayi B, Han L, Zhang Y, Asiguma M, Tianshu D, Maeda A, Kurane I, and Morikawa S. 2005. Antigen-capture enzyme-linked immunosorbent assay for the diagnosis of crimean-congo hemorrhagic fever using a novel monoclonal antibody. J Med Virol, 77: 83–88.

    PubMed  Article  CAS  Google Scholar 

  • Sanchez-Seco M P, and Navarro J M. 2005. Infections due to Toscana virus, West Nile virus, and other arboviruses of interest in Europe. Enferm Infecc Microbiol Clin, 23: 560–568.

    PubMed  Article  Google Scholar 

  • Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, and Akrami E. 2009. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med, 12: 151–153.

    PubMed  Google Scholar 

  • Shepherd A J, Swanepoel R, Leman P A, and Shepherd S P. 1986. Comparison of methods for isolation and titration of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol, 24: 654–656.

    PubMed  CAS  Google Scholar 

  • Soares-Weiser K, Thomas S, Thomson G, and Garner P. 2010. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect Dis, 10: 207.

    PubMed  Article  Google Scholar 

  • Tasdelen Fisgin N, Ergonul O, Doganci L, and Tulek N. 2009. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis, 28: 929–933.

    PubMed  Article  CAS  Google Scholar 

  • Tekin S, Bursali A, Mutluay N, Keskin A, and Dundar E. 2012. Crimean-Congo hemorrhagic fever virus in various ixodid tick species from a highly endemic area. Vet Parasitol, 186: 546–552.

    PubMed  Article  Google Scholar 

  • Tezer H, Sucakli I A, Sayli T R, Celikel E, Yakut I, Kara A, Tunc B, and Ergonul O. 2010. Crimean-Congo hemorrhagic fever in children. J Clin Virol, 48: 184–186.

    PubMed  Article  Google Scholar 

  • Tignor G H, and Hanham C A. 1993. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res, 22: 309–325.

    PubMed  Article  CAS  Google Scholar 

  • Turkdogan K A, Zorlu A, Engin A, Guven F M, Polat M M, Turgut O O, and Yilmaz M B. 2012. C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever. Int J Infect Dis, 16: e616–620.

    PubMed  Article  CAS  Google Scholar 

  • Vanhomwegen J, Alves M J, Zupanc T A, Bino S, Chinikar S, Karlberg H, Korukluoglu G, Korva M, Mardani M, Mirazimi A, Mousavi M, Papa A, Saksida A, Sharifi-Mood B, Sidira P, Tsergouli K, Wolfel R, Zeller H, and Dubois P. 2012. Diagnostic assays for crimean-congo hemorrhagic fever. Emerg Infect Dis, 18: 1958–1965.

    PubMed  Article  Google Scholar 

  • Vassilenko S M, Vassilev T L, Bozadjiev L G, Bineva I L, and Kazarov G Z. 1990. Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet, 335: 791–792.

    PubMed  Article  CAS  Google Scholar 

  • Watts D M, Ussery M A, Nash D, and Peters C J. 1989. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg, 41: 581–585.

    PubMed  CAS  Google Scholar 

  • Whitehouse C A. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res, 64: 145–160.

    PubMed  CAS  Google Scholar 

  • Xia H, Li P, Yang J, Pan L, Zhao J, Wang Z, Li Y, Zhou H, Dong Y, Guo S, Tang S, Zhang Z, Fan Z, Hu Z, Kou Z, and Li T. 2011. Epidemiological survey of Crimean-Congo hemorrhagic fever virus in Yunnan, China, 2008. Int J Infect Dis, 15: e459–463.

    PubMed  Article  Google Scholar 

  • Yen Y C, Kong L X, Lee L, Zhang Y Q, Li F, Cai B J, and Gao S Y. 1985. Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China. Am J Trop Med Hyg, 34: 1179–1182.

    PubMed  CAS  Google Scholar 

  • Zeller H. 2007. Laboratory Diagnosis of Crimean-Congo Hemorrhagic Fever, p. 233–243. In Ergonul O and Whitehouse C A (ed.), Crimean-Congo Hemorrhagic Fever: A Global Perspective. Springer, Dordrecht.

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serkan Öncü.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Öncü, S. Crimean-Congo hemorrhagic fever: An overview. Virol. Sin. 28, 193–201 (2013). https://doi.org/10.1007/s12250-013-3327-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-013-3327-4

Keywords

  • Crimean-Congo Hemorrhagic Fever
  • Epidemiology
  • Transmission
  • Pathogenesis
  • Diagnosis
  • Treatment
  • Prevention